Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer

Completed · Phase 1

Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy consisting of liposomal doxorubicin, paclitaxel, and carboplatin in treating patients who have untreated ovarian, peritoneal, or fallopian tube cancer.

Key facts

Study ID

NCT00003385

Run by

Gynecologic Oncology Group

People needed

48

Starts

1999-03-01

Last updated by the study team

2013-05-27

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• MBCCOP - Hawaii — Honolulu, Hawaii, United States
• Holden Comprehensive Cancer Center — Iowa City, Iowa, United States
• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• University of Texas Medical Branch — Galveston, Texas, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
• Norwegian Radium Hospital — Oslo, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.